nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrazepam—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.152	0.314	CbGbCtD
Nitrazepam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0713	0.148	CbGbCtD
Nitrazepam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0482	0.0998	CbGbCtD
Nitrazepam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.046	0.0952	CbGbCtD
Nitrazepam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.041	0.0849	CbGbCtD
Nitrazepam—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0401	0.0831	CbGbCtD
Nitrazepam—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0379	0.0785	CbGbCtD
Nitrazepam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.024	0.0498	CbGbCtD
Nitrazepam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0227	0.047	CbGbCtD
Nitrazepam—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.00345	0.00995	CcSEcCtD
Nitrazepam—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00342	0.00988	CcSEcCtD
Nitrazepam—Thinking abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00331	0.00955	CcSEcCtD
Nitrazepam—Withdrawal symptom—Prednisone—chronic obstructive pulmonary disease	0.00308	0.00889	CcSEcCtD
Nitrazepam—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00845	CcSEcCtD
Nitrazepam—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.00843	CcSEcCtD
Nitrazepam—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00274	0.00791	CcSEcCtD
Nitrazepam—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00271	0.00783	CcSEcCtD
Nitrazepam—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00271	0.00783	CcSEcCtD
Nitrazepam—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00268	0.00775	CcSEcCtD
Nitrazepam—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00266	0.00767	CcSEcCtD
Nitrazepam—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00763	CcSEcCtD
Nitrazepam—Mental disability—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00759	CcSEcCtD
Nitrazepam—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00259	0.00747	CcSEcCtD
Nitrazepam—Drug withdrawal syndrome—Prednisone—chronic obstructive pulmonary disease	0.00257	0.00743	CcSEcCtD
Nitrazepam—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00255	0.00736	CcSEcCtD
Nitrazepam—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00249	0.0072	CcSEcCtD
Nitrazepam—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00249	0.00719	CcSEcCtD
Nitrazepam—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00248	0.00717	CcSEcCtD
Nitrazepam—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00244	0.00705	CcSEcCtD
Nitrazepam—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00234	0.00677	CcSEcCtD
Nitrazepam—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00224	0.00647	CcSEcCtD
Nitrazepam—Acenocoumarol—CYP1A2—chronic obstructive pulmonary disease	0.00222	0.293	CrCbGaD
Nitrazepam—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00629	CcSEcCtD
Nitrazepam—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.00606	CcSEcCtD
Nitrazepam—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.0021	0.00605	CcSEcCtD
Nitrazepam—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.0021	0.00605	CcSEcCtD
Nitrazepam—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00597	CcSEcCtD
Nitrazepam—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00205	0.00593	CcSEcCtD
Nitrazepam—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00199	0.00573	CcSEcCtD
Nitrazepam—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00198	0.00572	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00195	0.00562	CcSEcCtD
Nitrazepam—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00194	0.00561	CcSEcCtD
Nitrazepam—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00193	0.00557	CcSEcCtD
Nitrazepam—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00186	0.00537	CcSEcCtD
Nitrazepam—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00181	0.00522	CcSEcCtD
Nitrazepam—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00179	0.00517	CcSEcCtD
Nitrazepam—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.00177	0.0051	CcSEcCtD
Nitrazepam—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00508	CcSEcCtD
Nitrazepam—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.00498	CcSEcCtD
Nitrazepam—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00495	CcSEcCtD
Nitrazepam—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00489	CcSEcCtD
Nitrazepam—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.00489	CcSEcCtD
Nitrazepam—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00166	0.0048	CcSEcCtD
Nitrazepam—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00477	CcSEcCtD
Nitrazepam—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00473	CcSEcCtD
Nitrazepam—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.0047	CcSEcCtD
Nitrazepam—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00469	CcSEcCtD
Nitrazepam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00162	0.00467	CcSEcCtD
Nitrazepam—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.00161	0.00464	CcSEcCtD
Nitrazepam—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00461	CcSEcCtD
Nitrazepam—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00453	CcSEcCtD
Nitrazepam—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00453	CcSEcCtD
Nitrazepam—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00156	0.00451	CcSEcCtD
Nitrazepam—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.0045	CcSEcCtD
Nitrazepam—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00154	0.00445	CcSEcCtD
Nitrazepam—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.00443	CcSEcCtD
Nitrazepam—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00441	CcSEcCtD
Nitrazepam—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00437	CcSEcCtD
Nitrazepam—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.00431	CcSEcCtD
Nitrazepam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.00431	CcSEcCtD
Nitrazepam—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00148	0.00427	CcSEcCtD
Nitrazepam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.00414	CcSEcCtD
Nitrazepam—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.00411	CcSEcCtD
Nitrazepam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.0041	CcSEcCtD
Nitrazepam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00141	0.00408	CcSEcCtD
Nitrazepam—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00407	CcSEcCtD
Nitrazepam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00406	CcSEcCtD
Nitrazepam—Shock—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00403	CcSEcCtD
Nitrazepam—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00397	CcSEcCtD
Nitrazepam—Tension—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00397	CcSEcCtD
Nitrazepam—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00393	CcSEcCtD
Nitrazepam—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00393	CcSEcCtD
Nitrazepam—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00389	CcSEcCtD
Nitrazepam—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00389	CcSEcCtD
Nitrazepam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00387	CcSEcCtD
Nitrazepam—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00382	CcSEcCtD
Nitrazepam—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00381	CcSEcCtD
Nitrazepam—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00379	CcSEcCtD
Nitrazepam—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00379	CcSEcCtD
Nitrazepam—Tension—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00375	CcSEcCtD
Nitrazepam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00372	CcSEcCtD
Nitrazepam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00372	CcSEcCtD
Nitrazepam—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00372	CcSEcCtD
Nitrazepam—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00371	CcSEcCtD
Nitrazepam—Acenocoumarol—ALB—chronic obstructive pulmonary disease	0.00128	0.169	CrCbGaD
Nitrazepam—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00368	CcSEcCtD
Nitrazepam—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00368	CcSEcCtD
Nitrazepam—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00365	CcSEcCtD
Nitrazepam—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00365	CcSEcCtD
Nitrazepam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00364	CcSEcCtD
Nitrazepam—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.0036	CcSEcCtD
Nitrazepam—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00358	CcSEcCtD
Nitrazepam—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00358	CcSEcCtD
Nitrazepam—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00358	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00354	CcSEcCtD
Nitrazepam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00351	CcSEcCtD
Nitrazepam—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00121	0.0035	CcSEcCtD
Nitrazepam—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.0035	CcSEcCtD
Nitrazepam—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00345	CcSEcCtD
Nitrazepam—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00344	CcSEcCtD
Nitrazepam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00344	CcSEcCtD
Nitrazepam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00344	CcSEcCtD
Nitrazepam—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00344	CcSEcCtD
Nitrazepam—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00343	CcSEcCtD
Nitrazepam—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00338	CcSEcCtD
Nitrazepam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00336	CcSEcCtD
Nitrazepam—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00336	CcSEcCtD
Nitrazepam—Bromazepam—CYP1A2—chronic obstructive pulmonary disease	0.00114	0.151	CrCbGaD
Nitrazepam—Infection—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00328	CcSEcCtD
Nitrazepam—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00328	CcSEcCtD
Nitrazepam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00324	CcSEcCtD
Nitrazepam—Infection—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00322	CcSEcCtD
Nitrazepam—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00321	CcSEcCtD
Nitrazepam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.0032	CcSEcCtD
Nitrazepam—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00318	CcSEcCtD
Nitrazepam—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0031	CcSEcCtD
Nitrazepam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00309	CcSEcCtD
Nitrazepam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00309	CcSEcCtD
Nitrazepam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00307	CcSEcCtD
Nitrazepam—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00307	CcSEcCtD
Nitrazepam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00302	CcSEcCtD
Nitrazepam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00302	CcSEcCtD
Nitrazepam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00297	CcSEcCtD
Nitrazepam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00295	CcSEcCtD
Nitrazepam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00295	CcSEcCtD
Nitrazepam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00294	CcSEcCtD
Nitrazepam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00294	CcSEcCtD
Nitrazepam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00292	CcSEcCtD
Nitrazepam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00291	CcSEcCtD
Nitrazepam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00291	CcSEcCtD
Nitrazepam—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00291	CcSEcCtD
Nitrazepam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.001	0.0029	CcSEcCtD
Nitrazepam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000997	0.00288	CcSEcCtD
Nitrazepam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000995	0.00287	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000988	0.00285	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000988	0.00285	CcSEcCtD
Nitrazepam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000987	0.00285	CcSEcCtD
Nitrazepam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000987	0.00285	CcSEcCtD
Nitrazepam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000987	0.00285	CcSEcCtD
Nitrazepam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000979	0.00283	CcSEcCtD
Nitrazepam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000979	0.00283	CcSEcCtD
Nitrazepam—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000975	0.00282	CcSEcCtD
Nitrazepam—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00097	0.0028	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000968	0.00279	CcSEcCtD
Nitrazepam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000967	0.00279	CcSEcCtD
Nitrazepam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000964	0.00278	CcSEcCtD
Nitrazepam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000961	0.00277	CcSEcCtD
Nitrazepam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000956	0.00276	CcSEcCtD
Nitrazepam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000951	0.00275	CcSEcCtD
Nitrazepam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000948	0.00274	CcSEcCtD
Nitrazepam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000947	0.00274	CcSEcCtD
Nitrazepam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000943	0.00272	CcSEcCtD
Nitrazepam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000943	0.00272	CcSEcCtD
Nitrazepam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000942	0.00272	CcSEcCtD
Nitrazepam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000938	0.00271	CcSEcCtD
Nitrazepam—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000935	0.0027	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000933	0.00269	CcSEcCtD
Nitrazepam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00269	CcSEcCtD
Nitrazepam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000924	0.00267	CcSEcCtD
Nitrazepam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000902	0.0026	CcSEcCtD
Nitrazepam—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000895	0.00258	CcSEcCtD
Nitrazepam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000894	0.00258	CcSEcCtD
Nitrazepam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000893	0.00258	CcSEcCtD
Nitrazepam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000893	0.00258	CcSEcCtD
Nitrazepam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000891	0.00257	CcSEcCtD
Nitrazepam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000889	0.00257	CcSEcCtD
Nitrazepam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000875	0.00253	CcSEcCtD
Nitrazepam—Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.000859	0.114	CrCbGaD
Nitrazepam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000843	0.00243	CcSEcCtD
Nitrazepam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000843	0.00243	CcSEcCtD
Nitrazepam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000842	0.00243	CcSEcCtD
Nitrazepam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000826	0.00238	CcSEcCtD
Nitrazepam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000821	0.00237	CcSEcCtD
Nitrazepam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000821	0.00237	CcSEcCtD
Nitrazepam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00081	0.00234	CcSEcCtD
Nitrazepam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00081	0.00234	CcSEcCtD
Nitrazepam—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000808	0.00233	CcSEcCtD
Nitrazepam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000804	0.00232	CcSEcCtD
Nitrazepam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000796	0.0023	CcSEcCtD
Nitrazepam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000793	0.00229	CcSEcCtD
Nitrazepam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000783	0.00226	CcSEcCtD
Nitrazepam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000783	0.00226	CcSEcCtD
Nitrazepam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000775	0.00224	CcSEcCtD
Nitrazepam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000767	0.00221	CcSEcCtD
Nitrazepam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000765	0.00221	CcSEcCtD
Nitrazepam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000757	0.00219	CcSEcCtD
Nitrazepam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000757	0.00219	CcSEcCtD
Nitrazepam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000741	0.00214	CcSEcCtD
Nitrazepam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000739	0.00213	CcSEcCtD
Nitrazepam—GABRG3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000731	0.00448	CbGpPWpGaD
Nitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000729	0.00447	CbGpPWpGaD
Nitrazepam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000728	0.0021	CcSEcCtD
Nitrazepam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000728	0.0021	CcSEcCtD
Nitrazepam—GABRR2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000724	0.00443	CbGpPWpGaD
Nitrazepam—GABRQ—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000724	0.00443	CbGpPWpGaD
Nitrazepam—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000723	0.00443	CbGpPWpGaD
Nitrazepam—Rash—Formoterol—chronic obstructive pulmonary disease	0.000722	0.00208	CcSEcCtD
Nitrazepam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000722	0.00208	CcSEcCtD
Nitrazepam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000721	0.00208	CcSEcCtD
Nitrazepam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000721	0.00208	CcSEcCtD
Nitrazepam—GABRB1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00072	0.00441	CbGpPWpGaD
Nitrazepam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000717	0.00207	CcSEcCtD
Nitrazepam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000717	0.00207	CcSEcCtD
Nitrazepam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000716	0.00207	CcSEcCtD
Nitrazepam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000715	0.00206	CcSEcCtD
Nitrazepam—GABRR1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000713	0.00437	CbGpPWpGaD
Nitrazepam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000713	0.00206	CcSEcCtD
Nitrazepam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000707	0.00204	CcSEcCtD
Nitrazepam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000706	0.00204	CcSEcCtD
Nitrazepam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000702	0.00203	CcSEcCtD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000692	0.00424	CbGpPWpGaD
Nitrazepam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000687	0.00198	CcSEcCtD
Nitrazepam—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000685	0.00198	CcSEcCtD
Nitrazepam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000682	0.00197	CcSEcCtD
Nitrazepam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00197	CcSEcCtD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000681	0.00417	CbGpPWpGaD
Nitrazepam—GABRA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000681	0.00417	CbGpPWpGaD
Nitrazepam—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000681	0.00197	CcSEcCtD
Nitrazepam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00197	CcSEcCtD
Nitrazepam—GABRR2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00068	0.00417	CbGpPWpGaD
Nitrazepam—GABRQ—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00068	0.00417	CbGpPWpGaD
Nitrazepam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00068	0.00196	CcSEcCtD
Nitrazepam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00068	0.00196	CcSEcCtD
Nitrazepam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000677	0.00195	CcSEcCtD
Nitrazepam—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000673	0.00412	CbGpPWpGaD
Nitrazepam—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000668	0.00193	CcSEcCtD
Nitrazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000667	0.00409	CbGpPWpGaD
Nitrazepam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000666	0.00192	CcSEcCtD
Nitrazepam—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000658	0.0019	CcSEcCtD
Nitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000654	0.00401	CbGpPWpGaD
Nitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000648	0.00397	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000645	0.00395	CbGpPWpGaD
Nitrazepam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.00185	CcSEcCtD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000637	0.0039	CbGpPWpGaD
Nitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000636	0.0039	CbGpPWpGaD
Nitrazepam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000631	0.00182	CcSEcCtD
Nitrazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000628	0.00385	CbGpPWpGaD
Nitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000625	0.00383	CbGpPWpGaD
Nitrazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000621	0.00381	CbGpPWpGaD
Nitrazepam—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000618	0.0818	CrCbGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000617	0.00378	CbGpPWpGaD
Nitrazepam—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000615	0.00377	CbGpPWpGaD
Nitrazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00061	0.00374	CbGpPWpGaD
Nitrazepam—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00061	0.00176	CcSEcCtD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000607	0.00372	CbGpPWpGaD
Nitrazepam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000599	0.00173	CcSEcCtD
Nitrazepam—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000598	0.00366	CbGpPWpGaD
Nitrazepam—GABRG3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000596	0.00365	CbGpPWpGaD
Nitrazepam—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000587	0.0036	CbGpPWpGaD
Nitrazepam—GABRB1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000587	0.0036	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000582	0.00357	CbGpPWpGaD
Nitrazepam—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000582	0.00356	CbGpPWpGaD
Nitrazepam—GABRR1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000581	0.00356	CbGpPWpGaD
Nitrazepam—Flurbiprofen—ALB—chronic obstructive pulmonary disease	0.00058	0.0768	CrCbGaD
Nitrazepam—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000577	0.00353	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000575	0.00352	CbGpPWpGaD
Nitrazepam—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000573	0.00351	CbGpPWpGaD
Nitrazepam—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000572	0.0035	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000567	0.00348	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000566	0.00346	CbGpPWpGaD
Nitrazepam—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000563	0.00345	CbGpPWpGaD
Nitrazepam—GABRG3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00056	0.00343	CbGpPWpGaD
Nitrazepam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000558	0.00342	CbGpPWpGaD
Nitrazepam—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000557	0.00161	CcSEcCtD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000555	0.0034	CbGpPWpGaD
Nitrazepam—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000555	0.0034	CbGpPWpGaD
Nitrazepam—GABRR2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000554	0.0034	CbGpPWpGaD
Nitrazepam—GABRQ—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000554	0.0034	CbGpPWpGaD
Nitrazepam—GABRB1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000552	0.00338	CbGpPWpGaD
Nitrazepam—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000548	0.00336	CbGpPWpGaD
Nitrazepam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000548	0.0725	CrCbGaD
Nitrazepam—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000547	0.00335	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000546	0.00334	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000542	0.00332	CbGpPWpGaD
Nitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000533	0.00327	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000533	0.00326	CbGpPWpGaD
Nitrazepam—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000525	0.00322	CbGpPWpGaD
Nitrazepam—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000522	0.0032	CbGpPWpGaD
Nitrazepam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00052	0.0015	CcSEcCtD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000519	0.00318	CbGpPWpGaD
Nitrazepam—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000515	0.00316	CbGpPWpGaD
Nitrazepam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000511	0.00147	CcSEcCtD
Nitrazepam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000507	0.00146	CcSEcCtD
Nitrazepam—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000505	0.0031	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000504	0.00309	CbGpPWpGaD
Nitrazepam—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000501	0.00307	CbGpPWpGaD
Nitrazepam—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000498	0.00144	CcSEcCtD
Nitrazepam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000496	0.00143	CcSEcCtD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000495	0.00303	CbGpPWpGaD
Nitrazepam—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000495	0.00143	CcSEcCtD
Nitrazepam—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000492	0.00301	CbGpPWpGaD
Nitrazepam—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000487	0.00298	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000487	0.00298	CbGpPWpGaD
Nitrazepam—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000485	0.0014	CcSEcCtD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000483	0.00296	CbGpPWpGaD
Nitrazepam—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000481	0.00295	CbGpPWpGaD
Nitrazepam—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000478	0.00293	CbGpPWpGaD
Nitrazepam—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000478	0.00138	CcSEcCtD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000475	0.00291	CbGpPWpGaD
Nitrazepam—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000471	0.00289	CbGpPWpGaD
Nitrazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00047	0.00288	CbGpPWpGaD
Nitrazepam—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00047	0.00288	CbGpPWpGaD
Nitrazepam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000468	0.00135	CcSEcCtD
Nitrazepam—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000467	0.00286	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000465	0.00285	CbGpPWpGaD
Nitrazepam—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000464	0.00284	CbGpPWpGaD
Nitrazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000459	0.00281	CbGpPWpGaD
Nitrazepam—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000458	0.00281	CbGpPWpGaD
Nitrazepam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000457	0.00132	CcSEcCtD
Nitrazepam—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000457	0.0028	CbGpPWpGaD
Nitrazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000456	0.0028	CbGpPWpGaD
Nitrazepam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00045	0.00275	CbGpPWpGaD
Nitrazepam—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00045	0.00275	CbGpPWpGaD
Nitrazepam—Infection—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00129	CcSEcCtD
Nitrazepam—Shock—Prednisone—chronic obstructive pulmonary disease	0.000443	0.00128	CcSEcCtD
Nitrazepam—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000442	0.00271	CbGpPWpGaD
Nitrazepam—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000439	0.00269	CbGpPWpGaD
Nitrazepam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000438	0.00268	CbGpPWpGaD
Nitrazepam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000435	0.00126	CcSEcCtD
Nitrazepam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000431	0.00264	CbGpPWpGaD
Nitrazepam—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000425	0.00261	CbGpPWpGaD
Nitrazepam—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000423	0.00259	CbGpPWpGaD
Nitrazepam—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00042	0.00257	CbGpPWpGaD
Nitrazepam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000415	0.00254	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000415	0.00254	CbGpPWpGaD
Nitrazepam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00041	0.00118	CcSEcCtD
Nitrazepam—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000404	0.00117	CcSEcCtD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000403	0.00247	CbGpPWpGaD
Nitrazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000401	0.00246	CbGpPWpGaD
Nitrazepam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00114	CcSEcCtD
Nitrazepam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000391	0.00113	CcSEcCtD
Nitrazepam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00039	0.00113	CcSEcCtD
Nitrazepam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000388	0.00112	CcSEcCtD
Nitrazepam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.00112	CcSEcCtD
Nitrazepam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00111	CcSEcCtD
Nitrazepam—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000384	0.00235	CbGpPWpGaD
Nitrazepam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000382	0.00234	CbGpPWpGaD
Nitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.00234	CbGpPWpGaD
Nitrazepam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000377	0.00231	CbGpPWpGaD
Nitrazepam—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000373	0.00229	CbGpPWpGaD
Nitrazepam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000371	0.00107	CcSEcCtD
Nitrazepam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000368	0.00106	CcSEcCtD
Nitrazepam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000367	0.00225	CbGpPWpGaD
Nitrazepam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000367	0.00225	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000363	0.00223	CbGpPWpGaD
Nitrazepam—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00036	0.00221	CbGpPWpGaD
Nitrazepam—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000358	0.00219	CbGpPWpGaD
Nitrazepam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000351	0.00215	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000348	0.00213	CbGpPWpGaD
Nitrazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000344	0.00211	CbGpPWpGaD
Nitrazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000342	0.00209	CbGpPWpGaD
Nitrazepam—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.00207	CbGpPWpGaD
Nitrazepam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000958	CcSEcCtD
Nitrazepam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000933	CcSEcCtD
Nitrazepam—SCN1A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000321	0.00196	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.00032	0.00196	CbGpPWpGaD
Nitrazepam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00092	CcSEcCtD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000318	0.00195	CbGpPWpGaD
Nitrazepam—Diazepam—ALB—chronic obstructive pulmonary disease	0.000316	0.0419	CrCbGaD
Nitrazepam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00089	CcSEcCtD
Nitrazepam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000307	0.00188	CbGpPWpGaD
Nitrazepam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000298	0.00086	CcSEcCtD
Nitrazepam—SCN1A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000287	0.00176	CbGpPWpGaD
Nitrazepam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000827	CcSEcCtD
Nitrazepam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00082	CcSEcCtD
Nitrazepam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000819	CcSEcCtD
Nitrazepam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000815	CcSEcCtD
Nitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.0017	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00027	0.00165	CbGpPWpGaD
Nitrazepam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00027	0.00165	CbGpPWpGaD
Nitrazepam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000772	CcSEcCtD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000254	0.00156	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000252	0.00154	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000244	0.00149	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000241	0.00148	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000233	0.00143	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000223	0.00137	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000223	0.00137	CbGpPWpGaD
Nitrazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000218	0.00134	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000218	0.00133	CbGpPWpGaD
Nitrazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.00132	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000208	0.00127	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000207	0.00127	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00124	CbGpPWpGaD
Nitrazepam—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.00122	CbGpPWpGaD
Nitrazepam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.0012	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000193	0.00118	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000178	0.00109	CbGpPWpGaD
Nitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00108	CbGpPWpGaD
Nitrazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000173	0.00106	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000169	0.00103	CbGpPWpGaD
Nitrazepam—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000167	0.00102	CbGpPWpGaD
Nitrazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000165	0.00101	CbGpPWpGaD
Nitrazepam—GABRQ—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000165	0.00101	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000162	0.000995	CbGpPWpGaD
Nitrazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.000971	CbGpPWpGaD
Nitrazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.000958	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000155	0.000951	CbGpPWpGaD
Nitrazepam—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000153	0.000938	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.00015	0.000918	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.000901	CbGpPWpGaD
Nitrazepam—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.000889	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000138	0.000844	CbGpPWpGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000136	0.000831	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000135	0.000825	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000134	0.000819	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000132	0.00081	CbGpPWpGaD
Nitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.000787	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000126	0.000775	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000125	0.000765	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000121	0.000742	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000119	0.000729	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000118	0.000725	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000114	0.0007	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000114	0.0007	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000113	0.000693	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000112	0.000685	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000112	0.000685	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000112	0.000684	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000111	0.00068	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000109	0.000667	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000107	0.000656	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000107	0.000655	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000106	0.000652	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000104	0.00064	CbGpPWpGaD
Nitrazepam—GABRR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000104	0.000635	CbGpPWpGaD
Nitrazepam—GABRQ—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.89e-05	0.000606	CbGpPWpGaD
Nitrazepam—GABRR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.89e-05	0.000606	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	9.67e-05	0.000592	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	9.61e-05	0.000588	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	9.59e-05	0.000587	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.39e-05	0.000576	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—IL6—chronic obstructive pulmonary disease	9.31e-05	0.00057	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.27e-05	0.000568	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.13e-05	0.000559	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	8.91e-05	0.000546	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	8.88e-05	0.000544	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	8.82e-05	0.00054	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	8.64e-05	0.00053	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.29e-05	0.000508	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—TNF—chronic obstructive pulmonary disease	8.23e-05	0.000504	CbGpPWpGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.15e-05	0.000499	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.03e-05	0.000492	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.84e-05	0.00048	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.84e-05	0.00048	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.74e-05	0.000474	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.73e-05	0.000473	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	7.63e-05	0.000467	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.59e-05	0.000465	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.5e-05	0.000459	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.2e-05	0.000441	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.1e-05	0.000435	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.09e-05	0.000434	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.86e-05	0.00042	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.83e-05	0.000418	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.73e-05	0.000412	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.66e-05	0.000408	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—IL6—chronic obstructive pulmonary disease	6.64e-05	0.000407	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.54e-05	0.000401	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.43e-05	0.000394	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.39e-05	0.000391	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.27e-05	0.000384	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.9e-05	0.000362	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.74e-05	0.000352	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.49e-05	0.000336	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.48e-05	0.000336	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.34e-05	0.000327	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.77e-05	0.000292	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.58e-05	0.000281	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.38e-05	0.000268	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.3e-05	0.000263	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.17e-05	0.000255	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.12e-05	0.000252	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.09e-05	0.000251	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.76e-05	0.00023	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.64e-05	0.000223	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.61e-05	0.000221	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.54e-05	0.000217	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.46e-05	0.000212	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.29e-05	0.000202	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.14e-05	0.000192	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.1e-05	0.00019	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.89e-05	0.000177	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.85e-05	0.000175	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.83e-05	0.000173	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.75e-05	0.000168	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.65e-05	0.000163	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.61e-05	0.00016	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.52e-05	0.000154	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.18e-05	0.000133	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.15e-05	0.000131	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2e-05	0.000122	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.93e-05	0.000118	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.91e-05	0.000117	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.89e-05	0.000116	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.74e-05	0.000107	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.71e-05	0.000105	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.64e-05	0.0001	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.61e-05	9.84e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.34e-05	8.21e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.32e-05	8.1e-05	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.29e-05	7.89e-05	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.23e-05	7.55e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.23e-05	7.54e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	7.15e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.94e-06	4.86e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.59e-06	4.65e-05	CbGpPWpGaD
